With sotro­vimab in the bal­ance, Bio­gen vet re­unites with George Scan­gos at Vir; First woman to chair PhRMA has more in store at Take­da

Vir Biotech­nol­o­gy is get­ting an­oth­er Bio­gen vet to join up as the start­up’s new glob­al CBO and EVP.

While Jo­han­na Friedl-Nader­er of­fi­cial­ly doesn’t start her first C-suite role for an­oth­er few weeks on March 2, she will join the com­pa­ny in the midst of con­flict­ing da­ta re­gard­ing its Glax­o­SmithK­line-part­nered Covid-19 an­ti­body, and armed with decades of work­ing at the re­cent­ly-em­broiled Bio­gen.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.